Dr. Sheng F. Kuo, MD

Dr. Kuo practices at NewYork-Presbyterian Queens in Flushing, New York, part of NewYork-Presbyterian Hospital.

Dr. Kuo's NPI, 1134317944, was assigned on October 5, 2007. Dr. Kuo graduated from St. George's University School of Medicine in 2003. Dr. Kuo holds New York license 2422521.

Dr. Kuo's primary practice is NewYork-Presbyterian Queens, at 56-45 Main Street, Flushing, NY 11355 in Queens County. The practice phone is (718) 670-2000.

Dr. Kuo's primary practice is NewYork-Presbyterian Queens in Flushing, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Nephrology Associates. Dmand AI also links Dr. Kuo to 3 more group practices and clinics, 3 medical groups and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kuo practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Kuo's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Kuo is board certified in nephrology by the American Board of Internal Medicine. Dr. Kuo is licensed in New York.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and kidney disease among the conditions Dr. Kuo treats.

CMS data shows 1,392 Medicare services from Dr. Kuo across 12 procedure codes in 2024, for 314 Medicare patients. Medicare paid $122,290 for them.

CMS counts 314 Medicare patients who saw Dr. Kuo in 2024. The largest group is 75 to 84, with 115 patients. 75% of them have chronic kidney disease, and 75% have diabetes. 49% are also on Medicaid. Their average risk score is 4.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kuo's median patient age at 72, with 46% women.

In 2024, Dr. Kuo wrote 2,561 Medicare Part D claims for 364 patients. 74% of them were for generic drugs. CMS names the drug for 2,207 of them, across 46 drugs with 11 or more claims each, at $738,384 in total drug cost. In 2023, CMS named 1,881 claims across 48 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 26 out of 100 for Dr. Kuo for performance year 2024, reported individually. Dr. Kuo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 12 papers to Dr. Kuo, published from 2010 to 2024. The most frequent topics are Thyroid Neoplasms, Carcinoma, Papillary and Iodine Radioisotopes. Dr. Kuo has published most often in J Formos Med Assoc. Dr. Kuo's most frequent co-authors are Choli Hartono, MD, Roy Nissim Alcalay, MD and Zainulabdeen Saad Abdulkadhim Al-Saedi, MD.

CMS Open Payments shows 192 general payments to Dr. Kuo from 24 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 53% of the total. Aurinia Pharma U.S., Inc. paid the most, $2,876.

Dmand AI lists 1 award for Dr. Kuo, most recently ACP Fellow in 2012.

Dr. Kuo graduated from St. George's University School of Medicine in 2003. Dr. Kuo is a member of ACP.

Dr. Kuo is in network with 15 carriers, including Aetna, United Healthcare and HCSC. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.